Seaport Therapeutics SPTX Interest Income (Expense), Nonoperating
Interest Income (Expense), Nonoperating at other companies
Other financials
Where this comes from
Reported directly by Seaport Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Seaport Therapeutics 's interest income (expense), nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Seaport Therapeutics 's interest income (expense), nonoperating?
- Seaport Therapeutics (SPTX) reported interest income (expense), nonoperating of $2.13M in Q1 2026.